Rory Douglas Speed: Seeing clearly for the first time with Omnipod® 5

Hello, it’s Rory*!

*Rory is a Sponsored Podder® and paid a fee for his contributions

I was diagnosed with type 1 diabetes at just 8 years old and have spent most of my life navigating the daily demands of managing diabetes. For years, that meant injecting insulin multiple times a day, but recently, I made the transition to the Omnipod® 5 Automated Insulin Delivery System, and the impact has been transformational.

I want to share my story to let others know the amazing benefits when the right technology meets real life; bringing greater freedom, confidence, and a new perspective to living with type 1 diabetes.

Podder, Rory standing with a lifebuoy, with one of his arm's raised Podder, Rory standing with a lifebuoy, with one of his arm's raised



How Omnipod Fits in My Life:

Peace of Mind

One of the biggest things is knowing the automated insulin delivery will take care of my levels overnight. I no longer wake up due to high or low glucose levels. Better sleep = way more clarity and presence.

Less Decisions

I know once my Pod is on, I can think less about injections, less about the maths, less about what insulin is already on board. The system does most of this for me. Game-changing!

Diabetes Get Smaller

I spend much less time thinking about my diabetes so I can focus more on other aspects of life – family, the gym, work – it’s all at the forefront instead of my diabetes now that Omnipod is sharing the load.

“I’ve been walking through this cloud for almost 20 years – and I had no idea it was even there – until I moved onto Omnipod 5.”

My top 3 things about Omnipod 5:

  • Simplicity it brings - it feels like I don’t have to do as much diabetes admin anymore
  • Freedom - because I'm doing less diabetes admin, I have more freedom to be me
  • It makes diabetes visible - yes, you can hide the Pod under clothing if you want to, but I love to wear my Pod loud and proud. 
Podder, Rory, sitting at the table with a meal and his phone in his hand Podder, Rory, sitting at the table with a meal and his phone in his hand
Open PEK Box Open PEK Box

Curious to try?

The Pod Experience Kit* is a real-feel, real-size, real-weight demo Pod, without the insulin, so you can: 

  • Experience what it’s like to wear a Pod 
  • See how discreet it can be 
  • Feel the freedom of going tubeless: at home, at work, or on the move 
Start your Omnipod journey
*The Demo Pod is a needle-free, non-functioning Pod. It will not deliver insulin. The Pod Experience Kit does not include a Controller.

More About Omnipod® 5

Omnipod 5 with pod and device Omnipod 5 with pod and device
  • The first and only tubeless, waterproof† hybrid closed loop system compatible with leading sensor brands 
  • Automatically adjusts insulin every five minutes1,2
  • Delivered more than 80% time in range with optimised settings3
3. Sawyer A, et al. Diabetes Technol Ther. 2026. Retrospective RWE of T1D users < 18 utilizing optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, and ≥5 bolus/day. Optimized settings: CF x TDI ≤1500 (83 mmol/L), I:C Ratio x TDI ≤350, Average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L).



Why Omnipod® 5?

icon tubeless pod

TUBELESS FREEDOM No Tubes. No Tangles.

Insulin is delivered via a small, waterproof† Pod that sticks directly to the body for up to 3 days of wear - no need for belt clips, pockets or tubing.

Icon - Brain

AUTOMATED INSULIN DELIVERY Less worry, more living.

Omnipod 5 integrates with your sensor and adjusts insulin every 5 minutes based on current and predicted glucose levels.

shirt icon

DISCREET & COMFORTABLE Wear it, forget it.

Slim, low-profile Pod fits comfortably under clothing and moves with you without the hassle of managing a tubed pump - perfect for sleep, activity, and everyday life.

Icon of trainer

LIVE LIFE UNINTERRUPTED Swim, shower†, sleep, and play.

Unlike tethered pumps that may need to be disconnected for certain activities, Omnipod 5 is designed to stay connected during daily activities.

Request a Pod Experience Kit

Please note that you should speak with your diabetes healthcare provider to assess your suitability for the Omnipod® Systems.

Indicates required field
Which of the following options best describes you?
Are you currently on Omnipod?
Type of Diabetes

Wir möchten, dass Ihr Pod-Erlebnis-Kit zu einer besonderen Erfahrung wird. Deshalb bieten wir zusätzliche Informationen zu Omnipod wie z.B. Webinare mit Produktdemonstrationen, E-Mails und persönlichen Kontakt mit unseren Experten zu unseren Produkten und Dienstleistungen.

Is this a mobile number or is it a home or work number?
Keep typing until you see your address.
Click here to enter your address manually.

Patient Information

Has this person ever used Omnipod before?
Type of Diabetes

Parent Information

Caregiver Information

Wir möchten, dass Ihr Pod-Erlebnis-Kit zu einer besonderen Erfahrung wird. Deshalb bieten wir zusätzliche Informationen zu Omnipod wie z.B. Webinare mit Produktdemonstrationen, E-Mails und persönlichen Kontakt mit unseren Experten zu unseren Produkten und Dienstleistungen.

Is this a mobile number or is it a home or work number?
Keep typing until you see your address.
Click here to enter your address manually.

A separate prescription is required for the sensor. The sensors are sold separately.

* [Requires compatible sensors. Bolus for meals and corrections are still needed.]

† The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please see sensor manufacturer user guide for sensor waterproof rating ‡ Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.

1. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in adults/adolescents as measured by CGM: ST = 64.7%, 3-mo Omnipod 5 = 73.9%, P<0.0001. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in children as measured by CGM: ST = 52.5%, 3-mo Omnipod 5 = 68.0%, P<0.0001. 

2. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2-5.9 yrs) with T1D. Study included a 14-daystandard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system.. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 57.2% vs 68.1%, P<0.0001. 

3. Sawyer A, et al. Diabetes Technol Ther. 2026. Retrospective RWE of T1D users < 18 utilizing optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, and ≥5 bolus/day. Optimized settings: CF x TDI ≤1500 (83 mmol/L), I:C Ratio x TDI ≤350, Average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L).